Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:15 PM
Ignite Modification Date:
2025-12-24 @ 5:15 PM
NCT ID:
NCT04233450
Brief Summary:
The BodyBabe studies aims to evaluate the perceptions that young mothers with anorexia nervosa (active or in remission) have of their own body and of the body of their child. The evaluations are carried out with self-assessment questionnaires and silhouette scales at three time points: D0 (during the stay at the maternity hospital), D15 (15 days after delivery) and M9 (9 months after delivery).
The output expected from this study is to validate a questionnaire to help healthcare providers to adapt their care of women with anorexia nervosa during the pregnancy and the post-partum period.
Detailed Description:
During the stay at maternity hospital, healthcare providers will identify potential candidates for the study on a daily basis according to the following criteria :
* BMI at the beginning of the pregnancy lower than 18,5 kg/m2 And/or
* History of anorexia nervosa
Tools and methods
The questionnaires used for the self-assessments are the following :
* Two questionnaires that evaluate the body satisfaction
* The Body Shape Questionnaire (BSQ)
* A questionnaire assessing the satisfaction of the mother regarding her baby's body shape (BodyBabe questionnaire).
* Two silhouette scales
* Stunkard scale also called Figure Rating Scale (FRS)5
* Infant Body Figure Drawings
* A questionnaire evaluating the severity of the eating disorders : Eating Attitude Test (EAT)
* A questionnaire detecting depression symptoms during post-partum : Edinburgh Post-natal Depression Scale (EPDS)
Study:
NCT04233450
Study Brief:
Protocol Section:
NCT04233450